Personalized Cancer Therapy Platform using OPCML Fragment and AI

A novel system integrating OPCML fragment-based cancer therapy with AI-driven predictive modeling, IoT-enabled biosensors, blockchain-based data sharing, and novel nanomaterials for targeted delivery, enabling personalized and effective cancer treatment.

Cancer treatment is a complex and challenging field, with current methods often lacking personalized approaches. The original patent disclosed the use of OPCML fragment for cancer therapy, but it had limitations in terms of efficacy, dosage, and treatment duration. The new inventive concept addresses these limitations by synergistically combining the OPCML fragment with other distinct technologies.

The new system consists of four key components: 1) AI-based predictive modeling for personalized therapy, utilizing genomic profiles of patients with ovarian cancer; 2) IoT-enabled biosensors for real-time monitoring of cancer biomarkers, detecting changes in OPCML expression levels; 3) a blockchain-based platform for secure sharing of OPCML-related research data and collaboration among researchers; and 4) a novel composition of matter comprising OPCML fragment and a targeted delivery nanomaterial. These components work together to provide a comprehensive and personalized cancer treatment approach.

The new claims introduce a synergistic combination of OPCML fragment with AI, IoT, blockchain, and novel nanomaterials, which is not obvious from the original patent. The inventive step lies in the integration of these distinct technologies to create a more powerful and effective system for cancer treatment.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT-enabled devices, or alternative blockchain platforms. Additionally, the OPCML fragment could be combined with other cancer therapeutic agents or used in conjunction with different types of cancer.

The personalized cancer therapy platform has significant commercial potential in the oncology market, with potential applications in ovarian cancer treatment and beyond. The market for cancer therapy is projected to grow significantly in the coming years, and this inventive concept is well-positioned to capitalize on this trend.